HPTN-052: clinical advantages from earlier treatment
1 October 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Conference reports
Hormonal contraception and the risk of HIV acquisition
1 October 2012. Related: Conference reports, Women's health.
Towards an HIV cure: Early developments reported at IAS, part 2
1 October 2012. Related: Conference reports, Cure-related research.
Online video interviews between researchers and activists
1 October 2012. Related: Conference reports, Antiretrovirals, Treatment access, HIV prevention and transmission, Cure-related research, Other news.
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 August 2012. Related: Conference reports.
IAS: social and political talks online as web casts
1 August 2012. Related: Conference reports, Treatment access, Treatment advocacy.
New booster – cobicistat as an alternative to ritonavir
1 August 2012. Related: Conference reports, Antiretrovirals.
Dolutegravir vs raltegravir in treatment-naive patients: 48 week results from the SPRING 2 study
1 August 2012. Related: Conference reports, Antiretrovirals.
Elvitegravir vs raltegravir: 96 week phase III results in treatment experienced patients
1 August 2012. Related: Conference reports, Antiretrovirals.
In vitro and animal data support safety profile BMS 986001: d4T-like NRTI currently in clinical trials
1 August 2012. Related: Conference reports, Antiretrovirals.
Switching to rilpivirine/tenofovir/FTC fixed dose combination from boosted-PI regimen: SPIRIT study draws the line at 24 weeks
1 August 2012. Related: Conference reports, Antiretrovirals.
Maraviroc plus atazanavir/ritonavir in a nuke-sparing regimen in treatment-naive patients
1 August 2012. Related: Conference reports, Antiretrovirals.
Five-year results from raltegravir registrational studies
1 August 2012. Related: Conference reports, Antiretrovirals.
First report: atazanavir-related gallstones (cholelithiasis)
1 August 2012. Related: Conference reports, Antiretrovirals, Side effects.
Paediatrics studies at 19th International AIDS Conference and the 4th International Workshop on HIV Pediatrics
1 August 2012. Related: Conference reports, Paediatric care.
Novel lopinavir/ritonavir sprinkle formulation for children in resource-limited settings
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Update on new antiretrovirals for children and adolescents
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Tenofovir prophylaxis for neonates
1 August 2012. Related: Conference reports, Pregnancy, Paediatric care.
Efavirenz levels variable in children in the CHAPAS-3 study
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Early initiation of ART is associated with growth recovery in children in NEVEREST-2
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
High prevalence of peripheral neuropathy in children taking d4T in rural South Africa
1 August 2012. Related: Conference reports, Paediatric care, Side effects.
Lipid profile in children in PREDICT: immediate versus deferred nevirapine-based ART
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
High levels of maraviroc in rectal tissue fail to protect macaques from SIV transmission following rectal exposure
1 August 2012. Related: Conference reports, HIV prevention and transmission.
Mechanisms for circumcision to reduce HIV transmission in different penile tissue: target cell differences rather than keratinisation
1 August 2012. Related: Conference reports, HIV prevention and transmission.
Towards an HIV cure: early developments reported
1 August 2012. Related: Conference reports, Cure-related research, Basic science and immunology.
Important publications launched at IAS 2012
1 August 2012. Related: Conference reports, Other news.
14th International Workshop on Co-morbidities and Adverse Drug Reactions (IWCADR), 19–21 July 2012, Washington
1 August 2012. Related: Conference reports.
Skeletal muscle toxicity and raltegravir
1 August 2012. Related: Conference reports, Antiretrovirals, Side effects.
Proteinuria as a potential early marker of tenofovir-related renal toxicity
1 August 2012. Related: Conference reports, Side effects.
Earlier and greater comorbidities reported in HIV positive cohort
1 August 2012. Related: Conference reports, Side effects.
20th International HIV Drug Resistance Workshop, 9–13 June 2012, Sitges
1 August 2012. Related: Conference reports.
In vitro resistance profile for BMS 986001
1 August 2012. Related: Conference reports, Drug resistance.
Recombination dynamics in case of MDR sub-type D following superinfection with wild-type sub-type B
1 August 2012. Related: Conference reports, Drug resistance.
Defective viral reservoir populations is common in patients on long-term suppressed ART
1 August 2012. Related: Conference reports, Drug resistance.
First case report of transmission with five-class resistance
1 August 2012. Related: Conference reports, Drug resistance.
New data on the Berlin patient: interpret with caution
1 August 2012. Related: Conference reports, Basic science and immunology, Drug resistance.
18th Annual BHIVA Conference, 18-20 April 2012, UK
1 June 2012. Related: Conference reports.
Half of gay men in London would chose oral PrEP to reduce risk of HIV
1 June 2012. Related: Conference reports, HIV prevention and transmission.
Recent infection is common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
1 June 2012. Related: Conference reports, HIV prevention and transmission.
One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated
1 June 2012. Related: Conference reports, Side effects, Coinfections and complications.
Hodgkin’s lymphoma: survival normalises to HIV negative rates despite more advanced disease at diagnosis
1 June 2012. Related: Conference reports, Coinfections and complications.
Promising outcomes from laser ablative treatment of AIN2/3 to prevent anal cancer
1 June 2012. Related: Conference reports, Coinfections and complications, Cancer and HIV.
KS in the HAART era includes patients with high CD4 and suppressed viral load: importance of KS chemotherapy for some patients in addition to ART
1 June 2012. Related: Conference reports, Coinfections and complications.
3rd vs 4th generation HIV testing: almost half of UK clinics out of step with national guidelines
1 June 2012. Related: Conference reports, HIV prevention and transmission.
Case reports of complications from ketamine use in two MSM on ritonavir-based combinations
1 June 2012. Related: Conference reports, PK and drug interactions.
Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations
1 June 2012. Related: Conference reports, PK and drug interactions, Side effects.
Outcomes from switches to atazanavir/r in London
1 June 2012. Related: Conference reports, Antiretrovirals, Side effects.
Intimate partner violence towards HIV positive women in the UK
1 June 2012. Related: Conference reports, Women's health.
13th International workshop on Clinical Pharmacology of HIV Therapy, 16-18 April 2012, Barcelona
1 June 2012. Related: Conference reports, PK and drug interactions.
Studies on pipeline ARVs
1 June 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Washout pharmacokinetics of transplacental raltegravir in neonates
1 June 2012. Related: Conference reports, PK and drug interactions.
Interactions between malaria drugs and etravirine or darunavir/r
1 June 2012. Related: Conference reports, PK and drug interactions.
No interaction between antimalarial amodiaquine and nevirapine
1 June 2012. Related: Conference reports, PK and drug interactions.
Pharmacokinetics of atazanavir/ritonavir plus raltegravir
1 June 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Atazanavir/ritonavir and voriconazole not to be coadministered
1 June 2012. Related: Conference reports, PK and drug interactions.
Milk thistle (silymarin) and darunavir/ritonavir
1 June 2012. Related: Conference reports, PK and drug interactions.
Echinacea and etravirine
1 June 2012. Related: Conference reports, PK and drug interactions.
Warfarin and ARVs: impact of African American race and ritonavir
1 June 2012. Related: Conference reports, PK and drug interactions.
19th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 March 2012, Seattle
1 June 2012. Related: Conference reports.
HIV and the brain: longitudinal results from CHARTER and other studies
1 June 2012. Related: Conference reports, Coinfections and complications.
Systolic blood pressure and risk of myocardial infarction in HIV infection
1 June 2012. Related: Conference reports, Coinfections and complications.
Risk of non-AIDS defining malignancies and immune suppression
1 June 2012. Related: Conference reports, Coinfections and complications.
Renal impairment in the D:A:D study
1 June 2012. Related: Conference reports, Antiretrovirals, Coinfections and complications.
Early data for rilpivirine long acting formulation supports further investigation for PrEP
1 June 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Hormonal contraception: HIV transmission and progression rates
1 June 2012. Related: Conference reports, Women's health.